Literature DB >> 1319693

The Cushing syndrome induced by bronchial carcinoid tumors.

A H Limper1, P C Carpenter, B Scheithauer, B A Staats.   

Abstract

OBJECTIVES: To define the clinical spectrum of bronchial carcinoid tumors in patients presenting with the Cushing syndrome, to evaluate the role of chest radiographs and computed tomography in their diagnosis, to review the characteristic histologic features, and to determine patient outcome.
DESIGN: Retrospective analysis of consecutive patients.
SETTING: A referral-based medical center. PATIENTS: Fifteen consecutive patients with the Cushing syndrome evaluated at the Mayo Clinic with histologically proven bronchial carcinoid tumors. MEASUREMENTS: Clinical, radiographic, and histologic features.
RESULTS: The Cushing syndrome was the initial clinical presentation, and bronchial carcinoid tumors were found later in all 15 patients. The diagnosis of carcinoid tumor was proved histologically in all cases. Ten biopsies showed typical carcinoid tumors, three were histologically atypical, and three were metastatic. Corticotropin was detected by immunostaining in seven of these tumors. Biochemical analysis showed marked elevations of circulating corticotropin with a mean serum value of 156 +/- 58 pmol/L (normal, 4 to 22 pmol/L). Additional clinical features included hypokalemia in six patients and glucocorticoid response to either high-dose dexamethasone or metyrapone in 6 of 13. These hormonally active carcinoid tumors were frequently radiographically occult, with 10 of 15 patients initially having normal chest radiographs. Computed tomography was successful in locating carcinoid tumors in five patients with negative chest radiographs evaluated after 1980. All five remaining patients with normal chest radiographs evaluated before 1980 eventually developed nodular lesions on standard chest radiography from 1 to 10 years later. Ten patients achieved complete remission and two patients, partial remission of the Cushing syndrome after surgical resection. Three patients continued to have symptomatic glucocorticoid excess due to metastatic disease.
CONCLUSIONS: Although uncommon, the Cushing syndrome may be the initial clinical manifestation of an otherwise indolent bronchial carcinoid tumor. Radiographic imaging of occult lesions can be successfully accomplished with computed tomography. Surgical resection is curative in most patients with this disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1319693     DOI: 10.7326/0003-4819-117-3-209

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  14 in total

Review 1.  Endocrine paraneoplastic syndromes with special reference to the elderly.

Authors:  L Bollanti; G Riondino; F Strollo
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

2.  Cushing's syndrome caused by ectopic corticotropin secretion by multiple peripheral pulmonary carcinoids and tumorlets of carcinoid type.

Authors:  N Ozbey; A Bozbora; G Kalayci; Y Kapran; D Yilmazbayhan; F Dizdaroglu; Y Orhan; E Sencer; S Molvalilar
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

3.  Ectopic Cushing's syndrome and pulmonary carcinoid tumour identified by [111In-DTPA-D-Phe1]octreotide.

Authors:  J Matte; F Roufosse; P Rocmans; A Schoutens; D Jacobovitz; J Mockel
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

4.  Ectopic cushing's syndrome caused by an 8 mm lung carcinoid localized by scintigram with the somatostatin analog111in-pentetreotide.

Authors:  João Filipe Raposo; Maria João Bugalho; Luís Gonçalves Sobrinho; Maria Conceição Pefeira; José Boavida; Margarida Loureiro; Maria Rosario Vieira; José Duro da Costa; José Manuel; Mendes Almeida; Kaiman Kovacs
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

5.  Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing's syndrome.

Authors:  B Vaidya; D Richardson; C J Hilton; P Kendall-Taylor
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

6.  Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.

Authors:  Aline Barbosa Moraes; Giselle F Taboada; Michel Pontes Carneiro; Leonardo Vieira Neto; Luiz Eduardo Armondi Wildemberg; Kalil Madi; Romeu Cortes Domingues; Mônica R Gadelha
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

7.  Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropin-secreting tumors.

Authors:  Marina S Zemskova; Bhaskar Gundabolu; Ninet Sinaii; Clara C Chen; Jorge A Carrasquillo; Millie Whatley; Iffat Chowdhury; Ahmed M Gharib; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2010-01-20       Impact factor: 5.958

8.  Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.

Authors:  M Nocaudie-Calzada; D Huglo; B Carnaille; C Proye; X Marchandise
Journal:  Eur J Nucl Med       Date:  1996-11

9.  A Minimally Invasive Approach to the Management of Bronchial Carcinoid Tumors Associated with Ectopic Cushing's Syndrome.

Authors:  Niall D. Ferguson; Eric C. Poulin; Victor L. Fornasier; Harley S. Smyth; Shereen Ezzat
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

10.  Plurihormonal Bronchial Carcinoid Associated with Ectopic Cushing's Syndrome.

Authors:  Donna Battaglia; Kalman Kovacs; Eva Horvath; Eric Poulin; Harley S. Smyth
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.